Throughout its history, the United States has led the world in protecting intellectual property (IP) rights.  On that foundation, we’ve also led the world in artistic, commercial and scientific innovation, particularly with lifesaving medicines and vaccines. Yet patent rights are under increasing assault, with some charging biopharmaceutical manufacturers with “antitrust” violations for utilizing and building upon their patents for the greater good. Those false critiques under the guise of “antitrust” typically rely upon an array of misleading and pejorative labels, the most prominent of which we address and debunk below:

[View Printable PDF]